August 31, 2026

Atrium Therapeutics, Inc. (RNA)

⚠️ No article content returned.

..

Cytokinetics, Inc. (CYTK) Stock Analysis: A Biotech Powerhouse with 52.45% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) stands out in the dynamic biotech sector, drawing investor interest with its innovative focus on muscle activators and inhibitors for treating serious diseases. Headquartered in South..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A 46% Upside Awaits in the Dynamic Cardiac Monitoring Market

iRhythm Holdings, Inc. (NASDAQ: IRTC) is carving out a significant niche in the healthcare sector, specifically within the medical devices industry. The company’s focus on digital healthcare solutions, particularly its..

RadNet, Inc. (RDNT) Stock Analysis: A Healthcare Play with 26.83% Potential Upside

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector specializing in diagnostics and research, presents a compelling opportunity for investors seeking growth in the medical imaging industry. With..

Merit Medical Systems (MMSI) Stock Analysis: Exploring a 12% Upside Potential for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector specializing in medical instruments and supplies, is garnering investor interest with a promising potential upside of 12.12%...

Bio-Techne Corp (TECH) Stock Analysis: Evaluating the Balance Between Growth Potential and Current Valuation

Investors eyeing the biotechnology sector are likely familiar with Bio-Techne Corp (NASDAQ: TECH), a formidable player in the healthcare industry. With a market capitalization of $11.35 billion, Bio-Techne is positioned..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a Promising 82% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA) captures the attention of investors with a compelling narrative in the healthcare sector, particularly within biotechnology. With a market cap of $2.09 billion, this U.S.-based..

Legend Biotech (LEGN): Analyst Consensus Predicts a 147.72% Potential Upside in Biotech Stock

Legend Biotech Corporation (NASDAQ: LEGN) is emerging as a compelling player in the biotechnology sector, particularly for investors who are keen on the dynamic field of cell therapy. With a..

Teleflex Incorporated (TFX) Stock Analysis: Exploring Growth Potential with a 9.93% Upside

Teleflex Incorporated (NYSE: TFX), a key player in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization of $5.92 billion, Teleflex has..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Potential Upside in Biotech Amidst Revenue Challenges

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, presents an intriguing opportunity for investors with a penchant for high-risk, high-reward ventures. With a market capitalization of..

Corcept Therapeutics Incorporat (CORT) Growth Potential: Biotech Powerhouse with a 23.81% Upside

Investors with a keen eye on the healthcare sector might find Corcept Therapeutics Incorporat (NASDAQ: CORT) an intriguing proposition. With a robust market cap of $12.31 billion, this Redwood City-based..

BrightSpring Health Services, I (BTSG) Stock Analysis: A 32.76% Upside Potential Amid Strong Buy Ratings

BrightSpring Health Services, I (BTSG), a major player in the healthcare sector, is garnering significant attention from investors thanks to its robust growth prospects and unanimous buy ratings from analysts...

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A 27% Upside Potential Amid Biotech Innovation

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is making waves with its innovative approach to tackling metabolic dysfunction-associated steatohepatitis (MASH). With a market capitalization of..

Vaxcyte, Inc. (PCVX) Investor Outlook: Biotech Stock with an 82% Potential Upside

Investors looking for opportunities in the biotechnology sector should consider Vaxcyte, Inc. (PCVX), a clinical-stage vaccine innovation company that has garnered significant attention for its promising pipeline and potential growth...

Glaukos Corporation (GKOS) Growth Potential: A Healthcare Innovator with a 9.61% Upside

As a pioneering force in the medical devices industry, Glaukos Corporation (NYSE: GKOS) stands at the intersection of innovation and healthcare. With its cutting-edge therapies targeting glaucoma, corneal disorders, and..

The Cooper Companies, Inc. (COO) Stock Analysis: Healthcare Giant with 14.51% Potential Upside

Investors keeping a keen eye on the healthcare sector may find The Cooper Companies, Inc. (NYSE: COO) an intriguing proposition. With a rich history dating back to 1958, this medical..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 17% Upside Potential Lights Up Investor Interest

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, stands out in the healthcare industry with its innovative pharmaceutical offerings. Based in Dublin, Ireland, Jazz Pharmaceuticals is..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking an 87.68% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX) presents an intriguing opportunity in the biotechnology space, especially for investors seeking exposure to the promising field of radiopharmaceuticals. With a market capitalization of $3.84..

Inspire Medical Systems, Inc. (INSP): Investor Outlook on Growth Prospects Amid Market Volatility

Inspire Medical Systems, Inc. (NYSE: INSP) stands at the intersection of technology and healthcare innovation, offering investors a unique opportunity to tap into the burgeoning medical devices sector. With a..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings and 9.54% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS), a prominent player in the biotechnology sector, has captured the attention of investors with its promising pipeline of genetic medicines and robust financial health. Headquartered..

Search

Funds

August 31, 2026

Search

Funds

August 31, 2026

FTSE 100

Funds